clofibrate has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 2 studies
angiokapsul: contains clofibrate & insoitolnicotinate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " A marginally toxic concentration of CPIB [0." | 1.28 | Sensitization of chronic myeloid leukemia cells to adriamycin cytotoxicity by clofibrate. ( Advani, S; Chitnis, M; Parekh, H; Satyamoorthy, K, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Parekh, H | 2 |
| Chitnis, M | 2 |
| Satyamoorthy, K | 1 |
| Advani, S | 1 |
2 other studies available for clofibrate and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Differential alteration of cellular lipids in drug sensitive and resistant P388 leukemia cells by clofibrate: effects on mitoxantrone cytotoxicity.
Topics: Animals; Cell Line; Clofibrate; DNA, Neoplasm; Doxorubicin; Drug Resistance; Humans; Leukemia P388; | 1991 |
Sensitization of chronic myeloid leukemia cells to adriamycin cytotoxicity by clofibrate.
Topics: Clofibrate; DNA; Doxorubicin; Drug Synergism; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positi | 1990 |